Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase

Sevil Korkmaz-Icöz, Tamás Radovits, Sivakkanan Loganathan, Shiliang Li, Mihály Ruppert, Kálmán Benke, Paige Brlecic, Csaba Szabo, Matthias Karck, Gábor Szabó

    Research output: Contribution to journalArticle

    Abstract

    limiting factor. Striving to optimize the use of this limited resource, the aspect that long distance procurement may increase the available donor pool must be taken into consideration. As poly(ADP-ribose)polymerase (PARP)-activation has been identified as a key pathway of reperfusion injury, we assessed the hypothesis that its inhibition would allow an extension of cold preservation time and protect the graft against ischaemia/reperfusion injury. METHODS: Hearts from donor rats were explanted, stored in a preservation solution (Custodiol) at 4 °C for 4 h or 8 h, and heterotopically transplanted. A vehicle or the PARP-inhibitor, INO-1001 (5 mg/kg), was administered during the reperfusion period. We evaluated posttransplant graft function with a Millar micromanometer at different left-ventricular volumes. Additionally, in organ bath experiments the effect of PARP-inhibition on endothelium-dependent and -independent vasorelaxation was evaluated after long-term cold ischaemic storage/warm reperfusion. RESULTS: PARP-inhibition resulted in a better systolic functional recovery of grafts submitted to 4 h and 8 h ischaemia. Furthermore, INO- 1001 decreased the left-ventricular end-diastolic pressure after 8 h of ischaemia. Coronary blood flow was significantly higher after PARPinhibition in comparison to controls. Endothelium-dependent vasorelaxation was significantly better in the INO-1001-groups than in the vehicle-treated transplant groups. After 24-h hypothermic storage, treatment of aortic ring with INO-1001 during reoxygenation significantly improved endothelial dysfunction. CONCLUSIONS: By inhibiting the PARP activation, INO-1001 can protect the graft and endothelium from the injury that is caused by prolonged cold myocardial ischaemia/reperfusion, thereby improving post-transplant graft function.

    Original languageEnglish (US)
    Article numberezw426
    Pages (from-to)829-835
    Number of pages7
    JournalEuropean Journal of Cardio-thoracic Surgery
    Volume51
    Issue number5
    DOIs
    StatePublished - May 1 2017

    Fingerprint

    Poly Adenosine Diphosphate Ribose
    Enzyme Activation
    Blood Vessels
    Poly(ADP-ribose) Polymerases
    Transplants
    Endothelium
    Reperfusion Injury
    Vasodilation
    Reperfusion
    Ischemia
    Cold Ischemia
    Myocardial Reperfusion
    Baths
    Myocardial Ischemia
    INO 1001
    Blood Pressure
    Wounds and Injuries

    Keywords

    • Endothelial dysfunction
    • Heart transplantation
    • Poly(ADP-ribose) polymerase

    ASJC Scopus subject areas

    • Surgery
    • Pulmonary and Respiratory Medicine
    • Cardiology and Cardiovascular Medicine

    Cite this

    Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase. / Korkmaz-Icöz, Sevil; Radovits, Tamás; Loganathan, Sivakkanan; Li, Shiliang; Ruppert, Mihály; Benke, Kálmán; Brlecic, Paige; Szabo, Csaba; Karck, Matthias; Szabó, Gábor.

    In: European Journal of Cardio-thoracic Surgery, Vol. 51, No. 5, ezw426, 01.05.2017, p. 829-835.

    Research output: Contribution to journalArticle

    Korkmaz-Icöz, Sevil ; Radovits, Tamás ; Loganathan, Sivakkanan ; Li, Shiliang ; Ruppert, Mihály ; Benke, Kálmán ; Brlecic, Paige ; Szabo, Csaba ; Karck, Matthias ; Szabó, Gábor. / Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase. In: European Journal of Cardio-thoracic Surgery. 2017 ; Vol. 51, No. 5. pp. 829-835.
    @article{025460d739c94462a58cc9f6f0fb7c77,
    title = "Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase",
    abstract = "limiting factor. Striving to optimize the use of this limited resource, the aspect that long distance procurement may increase the available donor pool must be taken into consideration. As poly(ADP-ribose)polymerase (PARP)-activation has been identified as a key pathway of reperfusion injury, we assessed the hypothesis that its inhibition would allow an extension of cold preservation time and protect the graft against ischaemia/reperfusion injury. METHODS: Hearts from donor rats were explanted, stored in a preservation solution (Custodiol) at 4 °C for 4 h or 8 h, and heterotopically transplanted. A vehicle or the PARP-inhibitor, INO-1001 (5 mg/kg), was administered during the reperfusion period. We evaluated posttransplant graft function with a Millar micromanometer at different left-ventricular volumes. Additionally, in organ bath experiments the effect of PARP-inhibition on endothelium-dependent and -independent vasorelaxation was evaluated after long-term cold ischaemic storage/warm reperfusion. RESULTS: PARP-inhibition resulted in a better systolic functional recovery of grafts submitted to 4 h and 8 h ischaemia. Furthermore, INO- 1001 decreased the left-ventricular end-diastolic pressure after 8 h of ischaemia. Coronary blood flow was significantly higher after PARPinhibition in comparison to controls. Endothelium-dependent vasorelaxation was significantly better in the INO-1001-groups than in the vehicle-treated transplant groups. After 24-h hypothermic storage, treatment of aortic ring with INO-1001 during reoxygenation significantly improved endothelial dysfunction. CONCLUSIONS: By inhibiting the PARP activation, INO-1001 can protect the graft and endothelium from the injury that is caused by prolonged cold myocardial ischaemia/reperfusion, thereby improving post-transplant graft function.",
    keywords = "Endothelial dysfunction, Heart transplantation, Poly(ADP-ribose) polymerase",
    author = "Sevil Korkmaz-Ic{\"o}z and Tam{\'a}s Radovits and Sivakkanan Loganathan and Shiliang Li and Mih{\'a}ly Ruppert and K{\'a}lm{\'a}n Benke and Paige Brlecic and Csaba Szabo and Matthias Karck and G{\'a}bor Szab{\'o}",
    year = "2017",
    month = "5",
    day = "1",
    doi = "10.1093/ejcts/ezw426",
    language = "English (US)",
    volume = "51",
    pages = "829--835",
    journal = "European Journal of Cardio-thoracic Surgery",
    issn = "1010-7940",
    publisher = "Elsevier",
    number = "5",

    }

    TY - JOUR

    T1 - Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase

    AU - Korkmaz-Icöz, Sevil

    AU - Radovits, Tamás

    AU - Loganathan, Sivakkanan

    AU - Li, Shiliang

    AU - Ruppert, Mihály

    AU - Benke, Kálmán

    AU - Brlecic, Paige

    AU - Szabo, Csaba

    AU - Karck, Matthias

    AU - Szabó, Gábor

    PY - 2017/5/1

    Y1 - 2017/5/1

    N2 - limiting factor. Striving to optimize the use of this limited resource, the aspect that long distance procurement may increase the available donor pool must be taken into consideration. As poly(ADP-ribose)polymerase (PARP)-activation has been identified as a key pathway of reperfusion injury, we assessed the hypothesis that its inhibition would allow an extension of cold preservation time and protect the graft against ischaemia/reperfusion injury. METHODS: Hearts from donor rats were explanted, stored in a preservation solution (Custodiol) at 4 °C for 4 h or 8 h, and heterotopically transplanted. A vehicle or the PARP-inhibitor, INO-1001 (5 mg/kg), was administered during the reperfusion period. We evaluated posttransplant graft function with a Millar micromanometer at different left-ventricular volumes. Additionally, in organ bath experiments the effect of PARP-inhibition on endothelium-dependent and -independent vasorelaxation was evaluated after long-term cold ischaemic storage/warm reperfusion. RESULTS: PARP-inhibition resulted in a better systolic functional recovery of grafts submitted to 4 h and 8 h ischaemia. Furthermore, INO- 1001 decreased the left-ventricular end-diastolic pressure after 8 h of ischaemia. Coronary blood flow was significantly higher after PARPinhibition in comparison to controls. Endothelium-dependent vasorelaxation was significantly better in the INO-1001-groups than in the vehicle-treated transplant groups. After 24-h hypothermic storage, treatment of aortic ring with INO-1001 during reoxygenation significantly improved endothelial dysfunction. CONCLUSIONS: By inhibiting the PARP activation, INO-1001 can protect the graft and endothelium from the injury that is caused by prolonged cold myocardial ischaemia/reperfusion, thereby improving post-transplant graft function.

    AB - limiting factor. Striving to optimize the use of this limited resource, the aspect that long distance procurement may increase the available donor pool must be taken into consideration. As poly(ADP-ribose)polymerase (PARP)-activation has been identified as a key pathway of reperfusion injury, we assessed the hypothesis that its inhibition would allow an extension of cold preservation time and protect the graft against ischaemia/reperfusion injury. METHODS: Hearts from donor rats were explanted, stored in a preservation solution (Custodiol) at 4 °C for 4 h or 8 h, and heterotopically transplanted. A vehicle or the PARP-inhibitor, INO-1001 (5 mg/kg), was administered during the reperfusion period. We evaluated posttransplant graft function with a Millar micromanometer at different left-ventricular volumes. Additionally, in organ bath experiments the effect of PARP-inhibition on endothelium-dependent and -independent vasorelaxation was evaluated after long-term cold ischaemic storage/warm reperfusion. RESULTS: PARP-inhibition resulted in a better systolic functional recovery of grafts submitted to 4 h and 8 h ischaemia. Furthermore, INO- 1001 decreased the left-ventricular end-diastolic pressure after 8 h of ischaemia. Coronary blood flow was significantly higher after PARPinhibition in comparison to controls. Endothelium-dependent vasorelaxation was significantly better in the INO-1001-groups than in the vehicle-treated transplant groups. After 24-h hypothermic storage, treatment of aortic ring with INO-1001 during reoxygenation significantly improved endothelial dysfunction. CONCLUSIONS: By inhibiting the PARP activation, INO-1001 can protect the graft and endothelium from the injury that is caused by prolonged cold myocardial ischaemia/reperfusion, thereby improving post-transplant graft function.

    KW - Endothelial dysfunction

    KW - Heart transplantation

    KW - Poly(ADP-ribose) polymerase

    UR - http://www.scopus.com/inward/record.url?scp=85019134954&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85019134954&partnerID=8YFLogxK

    U2 - 10.1093/ejcts/ezw426

    DO - 10.1093/ejcts/ezw426

    M3 - Article

    C2 - 28204209

    AN - SCOPUS:85019134954

    VL - 51

    SP - 829

    EP - 835

    JO - European Journal of Cardio-thoracic Surgery

    JF - European Journal of Cardio-thoracic Surgery

    SN - 1010-7940

    IS - 5

    M1 - ezw426

    ER -